COVID-19 Psychological Wellbeing for Healthcare Students (PoWerS)

PoWerS Study: Psychological Wellbeing for Healthcare Students: Evaluation of a COVID-19 Digital Learning Package

We have developed an online learning resource designed to support healthcare staff during and after the COVID-19 pandemic. This resource has been produced in anticipation of the psychological effect of working during this time. This is an open access, free, online resource available here: https://www.nottingham.ac.uk/toolkits/play_22794 It is designed to be relevant for healthcare staff, and we are evaluating it now with healthcare students as our next generation of healthcare staff. We are interested in knowing more about your views of healthcare students towards this package. This will help us to determine its value as a learning resource to support psychological wellbeing in healthcare students, alongside other welfare supports. The aim is to describe the views of healthcare students towards an e-learning package developed in response to COVID-19 on Psychological Wellbeing for Healthcare Workers.

Study Overview

• Status: Completed
• Conditions: Psychological Wellbeing
• Intervention / Treatment: Other: COVID-19 e-package: Psychological wellbeing for healthcare workers

Detailed Description

The investigators aim to:

• gather insight into the emotional highs and lows of being a healthcare student during the pandemic
• identify any facilitators, obstacles or barriers to accessing the e-package.
• identify perceptions of healthcare students towards the value of the e-package during and after the COVID19 pandemic.
• establish recommendations for longer-term support for psychological wellbeing in healthcare students.

Qualitative interviews will be conducted with up to 45 purposively sampled healthcare students who have accessed the e-learning resource. The interview will be semi-structured and include a measure of mental wellbeing (Warwick-Edinburgh Wellbeing Scale, 14-item - license received), and single items measures of job stressfulness, job satisfaction, presenteeism, turnover intentions and work engagement.

Findings will inform future supportive interventions for healthcare students.

• Study Type: Interventional
• Enrollment (Actual): 42
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United Kingdom
  • Nottingham, United Kingdom, NG7 2HA
    • University of Nottingham

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: ADULT; OLDER_ADULT; CHILD
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion criteria:

• Healthcare students (e.g. any students who are registered on a healthcare course).
• Ability to give informed consent.
• Ability to attend an individual interview (remotely).

Exclusion criteria:

• Not a registered healthcare student.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: SUPPORTIVE_CARE
• Allocation: NA
• Interventional Model: SINGLE_GROUP
• Masking: NONE

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: e-package: psychological wellbeing for healthcare workers; A COVID-19 educational package on psychological wellbeing for healthcare workers, accessible to all healthcare students.	Other: COVID-19 e-package: Psychological wellbeing for healthcare workers; All healthcare students have access to a COVID-19 educational learning package around psychological wellbeing (usual practice). In this study the investigators will conduct semi-structured qualitative interviews with healthcare students about their mental wellbeing, and use of this e-package.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Warwick-Edinburgh Mental Wellbeing Scale	14-item scale to measure mental wellbeing. Total scores range from 14 to 70 and higher scores indicate greater positive mental wellbeing.	Baseline
Qualitative Interviews with Healthcare Students	Users of the e-package	Once per study, telephone interview (during a 6-week interview period)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Single Item Measure of Global Job Stressfulness (Houdmont et al, 2019)	Single-item measure. Scores range from 1 to 5 and higher scores indicated greater job stressfulness.	Baseline
Single Item Global Job Satisfaction Measure (Dolbier et al, 2005)	Single-item measure. Scores range from 1 to 5 and higher scores indicated greater job satisfaction.	Baseline
Single Item Measure of Presenteeism (Aronsson & Gustafsson, 2004)	Single-item measure. Scores range from 1 to 4, with higher scores indicating greater presenteeism.	Baseline
Work Engagement (Shaufeli et al, 2006)	Dedication subscale of the 9-item Utrecht Work Engagement Scale (3 items will be used: 2, 3 and 4). Scores range from 0 to 6, with higher scores indicating greater work engagement.	Baseline
Single Item Measure of Turnover intentions	Single-item measure. Scored 1=no intent to leave, 2=intent to leave	Baseline

Collaborators and Investigators

• Sponsor: University of Nottingham

Study record dates

Study Major Dates

• Study Start (ACTUAL): June 13, 2020
• Primary Completion (ACTUAL): September 30, 2020
• Study Completion (ACTUAL): December 30, 2020

Study Registration Dates

• First Submitted: June 11, 2020
• First Submitted That Met QC Criteria: June 11, 2020
• First Posted (ACTUAL): June 12, 2020

Study Record Updates

• Last Update Posted (ACTUAL): August 27, 2021
• Last Update Submitted That Met QC Criteria: August 26, 2021
• Last Verified: August 1, 2021

More Information

Terms related to this study

• Other Study ID Numbers: PoWerS_June2020

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: Interview data will be made available on request (after study end).
• IPD Sharing Time Frame: Interview data will be available on request at study end (after publication of findings).
• IPD Sharing Access Criteria: On request.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No